Attovia Therapeutics ATTO

US equityMarket cap rank #3483Biotechnology

$15.72 −$0.70 (-4.26%)

Market open · Oct 8, 12:30 pm ET · After hours $16.42 0.00%

Open$16.27

Prev close$16.42

Day range$15.48 – $16.38

Volume143.3K

Market cap$717.64M

P/E (TTM)–

Dividend yield–

ATTO Stock News

Headlines matching Attovia Therapeutics or the ATTO ticker, most recent first.

LifeSci Capital Maintains Attovia Therapeutics(ATTO.US) With Buy Rating, Maintains Target Price $45Market news · 5 Sep 2026 · Direct mention
Citi Maintains Attovia Therapeutics(ATTO.US) With Buy Rating, Maintains Target Price $30Market news · 4 Sep 2026 · Direct mention
Analysts Offer Insights on NA Companies: Attovia Therapeutics, Inc. (ATTO) and Navan, Inc. Class A (NAVN)TipRanks · 4 Sep 2026 · Direct mention
Morgan Stanley Maintains Attovia Therapeutics(ATTO.US) With Buy Rating, Maintains Target Price $39Market news · 3 Sep 2026 · Direct mention
Analysts Offer Insights on NA Companies: Fastenal Company (FAST) and Attovia Therapeutics, Inc. (ATTO)TipRanks · 3 Sep 2026 · Direct mention
RBC Capital Maintains Attovia Therapeutics(ATTO.US) With Buy Rating, Maintains Target Price $45Market news · 3 Sep 2026 · Direct mention
LifeSci Capital Initiates Attovia Therapeutics(ATTO.US) With Buy Rating, Announces Target Price $45Market news · 31 Aug 2026 · Direct mention
RBC Capital Initiates Attovia Therapeutics(ATTO.US) With Buy Rating, Announces Target Price $45Market news · 31 Aug 2026 · Direct mention
Morgan Stanley Initiates Attovia Therapeutics(ATTO.US) With Buy Rating, Announces Target Price $39Market news · 31 Aug 2026 · Direct mention
Citi Initiates Attovia Therapeutics(ATTO.US) With Buy Rating, Announces Target Price $30Market news · 31 Aug 2026 · Direct mention

No comments yet — be the first to weigh in on ATTO.